Daniel Rowe

senior associate

Background

Dan is a European and Chartered UK Patent Attorney. He joined Dehns in 2001 after completing a BSc and then a PhD, both from the University of Bristol. He became an Associate of the firm in 2008 and Senior Associate in 2018.

 

Type of clients and client work

Dan’s clients range from small biotech start-ups and university spin-outs/technology transfer offices to multinational biotech/pharma corporations, with particular experience assisting UK, US and Scandinavian start-ups protect and exploit their IP and assess their freedom to operate in their chosen fields.

His work includes the drafting and prosecution of patent applications and the opposition of patents (offensive and defensive), including appeal work. Dan provides straightforward, business-oriented advice to clients on all aspects of patent law in this technical area, including patentability, infringement and validity analyses and commercially-focused assistance with the cost-effective development and management of global patent portfolios.

 

Expertise

His subject matter expertise covers the full spectrum of industrial and medical biotechnology. Within the health sector, he has a particular focus on molecular medicine; molecular diagnostics, biomarkers and personalised medicine; pharmaceuticals (human and veterinary); medical devices; advanced drug delivery; and wound healing products. His industrial practice has a particular focus on protein purification from blood products and advanced cell-factories for the industrial production of proteins. Dan also handles cases directed to microbiological and non-microbiological processes for the production of poly/oligosaccharides and engineered enzymes for removing contaminating nucleic acids from solutions.

 

Qualifications and Memberships

  • UK Chartered Patent Attorney, 2006
  • European Patent Attorney, 2006
  • Certificate in IP Law, University of London, 2003
  • Fellow of the Chartered Institute of Patent Attorneys
  • Member of the European Patent Institute
  • Basic Litigation Skills Course, 2017

 

Higher Education

BSc (Hons) (First Class), Biochemistry, University of Bristol, 1998

PhD “The intracellular mechanisms of thapsigargin-induced inhibition of human vascular smooth muscle cell proliferation”, University of Bristol, 2001

 

Other

Dan was recognised as a “rising star” in the 2018 edition of Managing Intellectual Property’s IP Stars publication.

Dan frequently writes on the IP industry and the Life Sciences sector; see below for his articles.

Contact details

Willow Court
West Way
Oxford
OX2 0JB
United Kingdom

+44 (0)1865 305 100 +44 (0)20 7353 8895

Department

biotechnology

Articles by Daniel Rowe

AI drug discovery comes of age AI drug discovery comes of age 03 Feb 2020 3 min read What price biotech innovation? What price biotech innovation? 09 Aug 2018 5 min read Life Sciences Patent Network Meeting, Boston 26 April 2018 – a report from the cutting edge Life Sciences Patent Network Meeting, Boston 26 April 2018 – a report from the cutting edge 27 Apr 2018 3 min read CRISPR patent pool moves closer CRISPR patent pool moves closer 18 Jul 2017 3 min read The Broccoli/Tomato wars – the EPO surrenders, but will the peace come at a cost? The Broccoli/Tomato wars – the EPO surrenders, but will the peace come at a cost? 28 Jun 2017 5 min read The European Commission reignites the Broccoli/Tomato patent wars The European Commission reignites the Broccoli/Tomato patent wars 11 Nov 2016 5 min read Is a CRISPR patent pool on the horizon? Is a CRISPR patent pool on the horizon? 12 Jun 2017 3 min read UK Court steps in to limit opportunities for gaming the patent system UK Court steps in to limit opportunities for gaming the patent system 09 Mar 2017 4 min read Do you know your Apple patents from your patent applications? Do you know your Apple patents from your patent applications? 21 Sep 2016 5 min read The UK and China enter a new phase of closer IP partnership The UK and China enter a new phase of closer IP partnership 09 Sep 2016 2 min read User-friendly UK Patent Rules on their way, but also get ready to say goodbye to omnibus claims User-friendly UK Patent Rules on their way, but also get ready to say goodbye to omnibus claims 06 Sep 2016 4 min read On the cusp of a new world of bespoke microorganisms – a new era for biotech innovation On the cusp of a new world of bespoke microorganisms – a new era for biotech innovation 26 Aug 2016 3 min read